Analgesic Efficacy of M-TAPA Block Accomplished Prior to Surgery in Patients Undergoing Laparoscopic Gynecological SurgeriesPhase 2NCT06039423
Modified Thoracoabdominal Nerves Block Through Perichondrial Approach: a New Strategy With a Wide Range of Utilization in Laparoscopic Gynecological Surgeries.
A Phase 2 study testing The M-TAPA block and Ketorolac in people with Analgesic Efficacy of M-TAPA Block Accomplished Prior to Surgery in Patients Undergoing Laparoscopic Gynecological Surgeries, run by Alexandria University at 1 site in Egypt.
Trial summary
The current study was to assess the analgesic effects of the modified thoracoabdominal nerves block through perichondrial approach (M-TAPA) block in patients undergoing gynecological laparoscopic surgeries.The primary goal was to evaluate the analgesic efficacy of M-TAPA block accomplished prior to surgery in patients… Read more about this study
- Who is it for?
- Ages 20 to 65 years, women only
- Conditions the study is for
- Analgesic Efficacy of M-TAPA Block Accomplished Prior to Surgery in Patients Undergoing Laparoscopic Gynecological Surgeries
- What is being tested?
- The M-TAPA block and Ketorolac
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 2 Jul 2023to 7 Sep 2023
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 65 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- adult female patients
- aged 20-65 years,
- normal coagulation profile,
- scheduled for ambulatory laparoscopic gynecological surgeries under general anaesthesia.
Who cannot join
- patient refusal,
- skin infection at the site of the needle puncture
- known allergies to any of the study medications
Trial locations and contacts
1 site in 1 country.
About this study
The current study was to assess the analgesic effects of the modified thoracoabdominal nerves block through perichondrial approach (M-TAPA) block in patients undergoing gynecological laparoscopic surgeries.The primary goal was to evaluate the analgesic efficacy of M-TAPA block accomplished prior to surgery in patients undergoing Laparoscopic gynecological surgeries
Read the detailed description
All patients were thoroughly assessed preoperatively by history evaluation as regards current medical condition and drug therapy, careful clinical examination and laboratory evaluations (complete blood picture, liver function and renal function tests). Explanation of the anaesthesia method was done to all patients and they were instructed wisely on how to utilize the 10 cm linear visual Analogue scale (VAS), with (0) denoting pain free state, whereas (10) stands for the worst intractable pain [9]. Fifteen minutes before induction, all patients were premedicated with i.v. midazolam 0.03 mg kg-1 In the operating room, an i.v. cannula was placed and secured, then standard monitoring including (pulse oximetry, ECG, non- invasive blood pressure and end tidal carbon dioxide) were applied to each patient using multichannel (Datex ohmeda S/5, Germany) monitor. Anaesthesia was induced with lidocaine (1mg/kg) followed by (1.5 - 2 mg/kg) propofol -till cessation of verbal contact- and (1-1.5 μg/kg) fentanyl. Endotracheal intubation was accomplished with rocuronium (1mg/kg) and a suitable sized tube. Anaesthesia was maintained with sevoflurane (1-2 %) with (50 %) oxygen in air. Controlled mechanical ventilation was provided to maintain ETCO2 between (33-35 mmHg) and an oxygen saturation of 98 %.
Patients will be randomly assigned- using closed envelope technique- into 2 groups (30 patient) each:
Group (M): The M-TAPA block will be combined with general anaesthesia. Group (C): (control group) conventional general anaesthesia receiving multimodal analgesia.
In group (M), after the induction of anaesthesia and with the patient in the supine position, the block was performed before starting of the surgical procedure as described by Tulgar et al. [8]. After surgical skin disinfection with 10 % povidone-iodine, it was covered with sterile surgical fenestrated drapes. A high frequency (6-12 MHz) US linear probe (Fujifilm Sonosite, Tokyo, Japan) covered with a sterile cover was placed in the sagittal plane on the 10 th costal margin in the midline. The probe was then angulated deeply to visualize the lower surface of the costal cartilage. Via in plane technique, a 21 gauge Tuohy needle (Stimuplex B-Braun Medical, Melsungen, Germany) was inserted cranially between the lower fascia of the costal cartilage and upper fascia of the transversus abdominis muscle by moving the needle tip towards the posterior aspect of the 10 th costal cartilage with caution not to cross the cranial edge of the 10th costal cartilage and 20 mL of bupivacaine (0.25 %) was injected bilaterally, in the midclavicular line.
In group (C), ketorolac 0.75 mg/kg and paracetamol 10 mg/kg were administered intravenously before surgical stimulus.
Inadequate analgesia expressed in the form of elevated blood pressure or accelerated heart rate 20 % above baseline value was managed by administration of 0.5 (μg/kg) fentanyl bolus as a rescue analgesia. Perioperative hypothermia was managed by warming of i.v fluids and forced air warming to exposed areas. Precise fluid replacement was provided to all subjects according to the standard guidelines applied during anaesthesia.
At the end of surgery, sevoflurane vaporizer was shut off followed by administration of 100 % oxygen. Muscle relaxant was reversed with neostigmine 0.04 mg/kg and atropine 0.02 mg/kg slowly i.v, after oropharyngeal secretions were suctioned. The tube was removed after ensuring that the patients regained consciousness, breathed spontaneously and respond to verbal command. IV ondansetron (8) mg was given to all patients to guard against postoperative nausea and vomiting.
Patients were transferred to the PACU, where monitoring of heart rate, arterial blood pressure, respiration, and temperature were done by recovery nurses unaware to the study design to avoid bias. Postoperative analgesia was administrated with paracetamol i.v. 1 gm/8 hr throughout the first 24 hours postoperatively and standardized intravenous patient-controlled analgesia (IV-PCA) with morphine (0.5 mg/mL, 2-mg bolus, lock-out period 10 mins, and 4 hrs limit of 20 mg) based on reaching the score of ≥ (4) VAS.
- Being tested
- The M-TAPA block, Ketorolac
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
The M-TAPA blockProcedure or surgery
A high frequency (6-12 MHz) US linear probe was placed in the sagittal plane on the 10 th costal margin in the midline. The probe was then angulated deeply to visualize the lower surface of the costal cartilage. Via in plane technique, a 21 gauge Tuohy needle was inserted cranially between the lower fascia of the costal cartilage and upper fascia of the transversus abdominis muscle by moving the needle tip towards the posterior aspect of the 10 th costal cartilage and 20 mL bupivacaine (0.25 %) was injected.
KetorolacDrug
conventional general anaesthesia receiving multimodal analgesia
| Study group | Role | What they receive |
|---|---|---|
| Group (M) | Active comparator | The M-TAPA block will be combined with general anaesthesia.
: Receives: Procedure: The M-TAPA block |
| Group (C) | Placebo comparator | (control group) conventional general anaesthesia receiving multimodal analgesia. Receives: Drug: Ketorolac |
What is being measured
The primary outcome is the main question the study is designed to answer.
Total dose of fentanyl consumption
analgesic efficacy of M-TAPA block
Measured: after 1 hour postoperative
Secondary outcomes (1)
postoperative morphine given (mg) in the first 24 hrs
analgesic efficacyof M-TAPA block
Measured: after 24 hours postoperatively
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Sep 2023
- Study start2 Jul 2023
- Primary completion15 Aug 2023
- Study completion7 Sep 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Analgesic Efficacy of M-TAPA Block Accomplished Prior to Surgery in Patients Undergoing Laparoscopic Gynecological SurgeriesStudies of the same condition, open and under way.
- More trials run by Alexandria UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alexandria University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06039423
- Sponsor's protocol ID
- 0306061
- Status last verified
- Jul 2023
- First submitted
- 9 Sep 2023
- Last updated
- 15 Sep 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Modified Thoracoabdominal Nerves Block Through Perichondrial Approach: a New Strategy With a Wide Range of Utilization in Laparoscopic Gynecological Surgeries.
- ClinicalTrials.gov ID
- NCT06039423
- Acronym / sponsor ID
- 0306061
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Alexandria UniversityUniversity, hospital or other
- Study start
- 2 Jul 2023 (actual)
- Primary completion
- 15 Aug 2023 (actual)
- Study completion
- 7 Sep 2023 (actual)
- First posted
- 15 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The current study was to assess the analgesic effects of the modified thoracoabdominal nerves block through perichondrial approach (M-TAPA) block in patients undergoing gynecological laparoscopic surgeries.The primary goal was to evaluate the analgesic efficacy of M-TAPA block accomplished prior to surgery in patients undergoing Laparoscopic gynecological surgeries
Detailed description
All patients were thoroughly assessed preoperatively by history evaluation as regards current medical condition and drug therapy, careful clinical examination and laboratory evaluations (complete blood picture, liver function and renal function tests). Explanation of the anaesthesia method was done to all patients and they were instructed wisely on how to utilize the 10 cm linear visual Analogue scale (VAS), with (0) denoting pain free state, whereas (10) stands for the worst intractable pain [9]. Fifteen minutes before induction, all patients were premedicated with i.v. midazolam 0.03 mg kg-1 In the operating room, an i.v. cannula was placed and secured, then standard monitoring including (pulse oximetry, ECG, non- invasive blood pressure and end tidal carbon dioxide) were applied to each patient using multichannel (Datex ohmeda S/5, Germany) monitor. Anaesthesia was induced with lidocaine (1mg/kg) followed by (1.5 - 2 mg/kg) propofol -till cessation of verbal contact- and (1-1.5 μg/kg) fentanyl. Endotracheal intubation was accomplished with rocuronium (1mg/kg) and a suitable sized tube. Anaesthesia was maintained with sevoflurane (1-2 %) with (50 %) oxygen in air. Controlled mechanical ventilation was provided to maintain ETCO2 between (33-35 mmHg) and an oxygen saturation of 98 %.
Patients will be randomly assigned- using closed envelope technique- into 2 groups (30 patient) each:
Group (M): The M-TAPA block will be combined with general anaesthesia. Group (C): (control group) conventional general anaesthesia receiving multimodal analgesia.
In group (M), after the induction of anaesthesia and with the patient in the supine position, the block was performed before starting of the surgical procedure as described by Tulgar et al. [8]. After surgical skin disinfection with 10 % povidone-iodine, it was covered with sterile surgical fenestrated drapes. A high frequency (6-12 MHz) US linear probe (Fujifilm Sonosite, Tokyo, Japan) covered with a sterile cover was placed in the sagittal plane on the 10 th costal margin in the midline. The probe was then angulated deeply to visualize the lower surface of the costal cartilage. Via in plane technique, a 21 gauge Tuohy needle (Stimuplex B-Braun Medical, Melsungen, Germany) was inserted cranially between the lower fascia of the costal cartilage and upper fascia of the transversus abdominis muscle by moving the needle tip towards the posterior aspect of the 10 th costal cartilage with caution not to cross the cranial edge of the 10th costal cartilage and 20 mL of bupivacaine (0.25 %) was injected bilaterally, in the midclavicular line.
In group (C), ketorolac 0.75 mg/kg and paracetamol 10 mg/kg were administered intravenously before surgical stimulus.
Inadequate analgesia expressed in the form of elevated blood pressure or accelerated heart rate 20 % above baseline value was managed by administration of 0.5 (μg/kg) fentanyl bolus as a rescue analgesia. Perioperative hypothermia was managed by warming of i.v fluids and forced air warming to exposed areas. Precise fluid replacement was provided to all subjects according to the standard guidelines applied during anaesthesia.
At the end of surgery, sevoflurane vaporizer was shut off followed by administration of 100 % oxygen. Muscle relaxant was reversed with neostigmine 0.04 mg/kg and atropine 0.02 mg/kg slowly i.v, after oropharyngeal secretions were suctioned. The tube was removed after ensuring that the patients regained consciousness, breathed spontaneously and respond to verbal command. IV ondansetron (8) mg was given to all patients to guard against postoperative nausea and vomiting.
Patients were transferred to the PACU, where monitoring of heart rate, arterial blood pressure, respiration, and temperature were done by recovery nurses unaware to the study design to avoid bias. Postoperative analgesia was administrated with paracetamol i.v. 1 gm/8 hr throughout the first 24 hours postoperatively and standardized intravenous patient-controlled analgesia (IV-PCA) with morphine (0.5 mg/mL, 2-mg bolus, lock-out period 10 mins, and 4 hrs limit of 20 mg) based on reaching the score of ≥ (4) VAS.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group (M) | Active comparator | Procedure: The M-TAPA blockThe M-TAPA block will be combined with general anaesthesia. : |
| Group (C) | Placebo comparator | Drug: Ketorolac(control group) conventional general anaesthesia receiving multimodal analgesia. |
Who may qualify
- Ages
- 20 to 65 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- adult female patients
- aged 20-65 years,
- normal coagulation profile,
- scheduled for ambulatory laparoscopic gynecological surgeries under general anaesthesia.
Key exclusion criteria (3 listed)
- patient refusal,
- skin infection at the site of the needle puncture
- known allergies to any of the study medications
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| The M-TAPA blockA high frequency (6-12 MHz) US linear probe was placed in the sagittal plane on the 10 th costal margin in the midline. The probe was then angulated deeply to visualize the lower surface of the costal cartilage. Via in plane technique, a 21 gauge Tuohy needle was inserted cranially between the lower fascia of the costal cartilage and upper fascia of the transversus abdominis muscle by moving the needle tip towards the posterior aspect of the 10 th costal cartilage and 20 mL bupivacaine (0.25 %) was injected. | Procedure or surgery | Group (M) |
| Ketorolacconventional general anaesthesia receiving multimodal analgesia | Drug | Group (C) |
Primary outcome
Total dose of fentanyl consumption
Time frame: after 1 hour postoperative
analgesic efficacy of M-TAPA block
1 secondary outcome
postoperative morphine given (mg) in the first 24 hrs
Time frame: after 24 hours postoperatively
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2023.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing The M-TAPA block and Ketorolac in people with Analgesic Efficacy of M-TAPA Block Accomplished Prior to Surgery in Patients Undergoing Laparoscopic Gynecological Surgeries, run by Alexandria University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Total dose of fentanyl consumption (time frame: after 1 hour postoperative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2023.